USP 382: Step-by-Step Operational Implementation

Introduction

Implementing USP 382 requires a structured and multidisciplinary approach. It is not about performing individual tests, but about building an audit-ready functional qualification process.

Phase 1 – Preliminary Assessment

• Definition of the system (vial, syringe, cartridge)
• Analysis of clinical use
• Risk profile assessment
• Identification of applicable requirements

Watch out for…
Applying tests that are not relevant to the real use of the product.

Phase 2 – Selection of the Elastomeric Component

• Review of supplier documentation
• USP compliance data
• Assessment of coatings and treatments

Common mistake:
Relying exclusively on supplier data without verification in the final system.

Phase 3 – Definition of the Test Plan

The test plan must include:

• Closed container system integrity testing
• Fragmentation assessment
• Needle/spike penetration testing
• Self-sealing performance
• Plunger force testing

Each test must have properly justified acceptance criteria.

Phase 4 – Test Execution

• Representative samples
• Worst-case conditions
• Appropriate instrumentation

GMP Best Practice
Whenever possible, test samples at end of shelf life.

Phase 5 – Results Analysis

• Comparison against defined criteria
• Trend evaluation
• Deviation management

Phase 6 – Reporting

The report must describe:

• Rationale
• Method
• Results
• Conclusions

Phase 7 – Integration into Routine Operations

• Change control
• Supplier management
• Periodic review

Operational Checklist

• System defined ✔
• Risk analysis performed ✔
• QA-approved test plan ✔
• Tests executed ✔
• Audit-ready report ✔

Realistic Scenario

Change of stopper supplier → full USP 382 re-evaluation required prior to regulatory variation submission.

Would you like a complete framework with ready-to-use checklists and templates?
Explore the full guide on GuideGxP.com